Enrica Rumiato
Padova, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Identification of host variants associated with overall survival of esophageal cancer patients receiving platinum-based therapy.
Journal: Pharmacogenomics
Published: April 15, 2020
Association Between ERCC1 rs3212986 and ERCC2/XPD rs1799793 and OS in Patients With Advanced Esophageal Cancer.
Journal: Frontiers in oncology
Published: December 03, 2018
Detection of genetic alterations in cfDNA as a possible strategy to monitor the neoplastic progression of Barrett's esophagus.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: April 04, 2017
Predictive role of host constitutive variants in neoadjuvant therapy of esophageal cancer.
Journal: Pharmacogenomics
Published: May 17, 2016
Liquid biopsy as a novel tool to monitor the carcinogenesis of Barrett's esophagus.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: December 30, 2015
A germline predictive signature of response to platinum chemotherapy in esophageal cancer.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: October 10, 2015
Predictive markers in elderly patients with estrogen receptor-positive breast cancer treated with aromatase inhibitors: an array-based pharmacogenetic study.
Journal: The pharmacogenomics journal
Published: May 20, 2015
Genetic risk of subsequent esophageal cancer in lymphoma and breast cancer long-term survival patients: a pilot study.
Journal: The pharmacogenomics journal
Published: January 08, 2015
Genetic features of metachronous esophageal cancer developed in Hodgkin's lymphoma or breast cancer long-term survivors: an exploratory study.
Journal: PloS one
Published: October 09, 2014
Clinical and Genetic Factors Associated With Severe Hematological Toxicity in Glioblastoma Patients During Radiation Plus Temozolomide Treatment: A Prospective Study.
Journal: American journal of clinical oncology
Published: September 26, 2013
ERCC1 C8092A (rs3212986) polymorphism as a predictive marker in esophageal cancer patients treated with cisplatin/5-FU-based neoadjuvant therapy.
Journal: Pharmacogenetics and genomics
Published: August 22, 2013
DMET™ (Drug-Metabolizing Enzymes and Transporters) microarray analysis of colorectal cancer patients with severe 5-fluorouracil-induced toxicity.
Journal: Cancer chemotherapy and pharmacology
Published: May 07, 2013
Last Updated: 09/26/2026